ELECTROMED, INC.
Electromed (NYSE American:ELMD) develops, manufactures, and markets innovative airway clearance therapy products, including SmartVest® Airway Clearance System, for use primarily in the home setting.
“The Equity Group has surpassed our expectations on a variety of fronts, namely their high level of engagement and responsiveness, their ability to craft communications that reflect a real understanding of our business and management style, the introductions to high quality investment professionals, and the expert, frank counsel on which we have come to rely. We truly value our partnership with The Equity Group.”
Kathleen Skarvan
President & CEO
Electromed, Inc.
NYSE American: ELMD
THE START
  • Commenced services in mid-2016.
  • Market cap was approximately $35 million and 90-day moving average daily volume approximated 70,000 shares.
Our Role
  • Planned and managed a strategic communications program.
  • Created a new, comprehensive investor presentation.
  • Spearheaded implementation of a professional investor relations section for the Company’s website.
  • Re-established quarterly conference calls.
  • Drafted conference call scripts, shareholder letters, earnings releases and other announcements.
  • Arranged meetings with investors and analysts in various cities.
  • Served as a trusted contact; handle phone and email inquiries from investors.
  • Provided advisory on a range of subjects related to public company life.
  • Provided market intelligence on an array of company and peer matters.
  • Performed administrative IR duties, including arranging quarterly conference calls, fulfilling requests for investment materials, maintaining the email list, etc.
^
RESULTS
  • Market cap topped $140 million and 90-day moving average daily volume exceeded 175,000 shares in mid-2020.
  • Arranged introductory meetings with MedTech analysts at an array of firms; Colliers and Northland launched coverage.
  • Arranged introductory meetings/calls with a number of institutions that became shareholders.
  • Added to Russell 3000® Index.
PREVIOUS CASE STUDY
NEXT CASE STUDY